Why the study?
Does enalaprilat improve regional myocardial perfusion and coronary flow reserve in dogs with pacing-induced dilated cardiomyopathy?
Does enalaprilat improve regional myocardial perfusion and coronary flow reserve in dogs with pacing-induced dilated cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Enalaprilat improves transmural myocardial perfusion and restores subendocardial coronary flow reserve in a canine model of dilated cardiomyopathy via a bradykinin-mediated, NO-dependent mechanism not shared by AT1 antagonists.
BACKGROUND: ACE inhibitors have been used extensively in heart failure, where they induce systemic vasodilatation. ACE inhibitors have also been shown to reduce ischemic events after myocardial infarction, although their mechanisms of action on the coronary circulation are less well understood. The purpose of the present study was to determine the effects and the mechanism of action of the ACE inhibitor enalaprilat and the AT1 antagonist losartan on regional myocardial perfusion and coronary flow and vasodilator reserve in conscious dogs with pacing-induced dilated cardiomyopathy (DCM). METHODS AND RESULTS: Twenty-seven conscious, chronically instrumented dogs were studied during advanced stages of dilated cardiomyopathy, which was induced by rapid pacing. Enalaprilat (1.25 mg IV) improved transmural distribution (endocardial/epicardial ratio) at rest (baseline, 0.91+/-0.11; enalaprilat, 1.02+/-0.07 mL/min per g; P<0.05) and during atrial pacing (baseline, 0.82+/-0.11; enalaprilat, 0.98+/-0.07; P<0.05). Enalaprilat also restored subendocardial coronary flow reserve (CFR) (baseline CFR, 1.89+/-0.11; enalaprilat CFR, 2.74+/-0.33; P<0.05) in DCM. These effects were abolished by pretreatment with the NO synthase inhibitor nitro-L-arginine. The effects were recapitulated by the bradykinin(2) receptor agonist cereport but not by the AT1 antagonist losartan. CONCLUSIONS: The ACE inhibitor enalaprilat improves transmural myocardial perfusion at rest and after chronotropic stress and restores impaired subendocardial coronary flow and vasodilator reserve in DCM. The effects of enalaprilat were bradykinin mediated and NO dependent and were not recapitulated by losartan. These data suggest beneficial effects of ACE inhibitors on the coronary circulation in DCM that are not shared by AT1 receptor antagonists.
No takes yet. Share an insight, caveat, or question.
Nikolaidis et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: